Pretreatment with a single, low dose of recombinant human thyrotropin allows dose reduction of radioiodine therapy in patients with nodular goiter

S.J. Bonnema, V.E. Nielsen, L. Hegedüs

Publikation: Bidrag til tidsskriftTidsskriftartikelForskning

OriginalsprogEngelsk
TidsskriftThe Journal of Clinical Endocrinology & Metabolism
Vol/bind88
Sider (fra-til)6113-6114
ISSN0021-972X
DOI
StatusUdgivet - 2003

Citationsformater